
é¢å ææç察çæé
ã³ãããŠã€ã«ã¹åã®ãã®ã«ãªãã®ã§ãæ°ããã¢ããããŒããå¿ èŠãšãªããŸããã蚺çæãéèšããéã«äœæããé¢å ææç察çæéã§ãã蚺çæã»èšªåçè·ã¹ããŒã·ã§ã³ã§å¿ èŠã«å¿ããŠãç·šéããŠæŽ»çšããŠäžããã
幎ã«2å宿œããããšãæšå¥šãããŠããé¢å ææç察çç ä¿®ã«çšããŠèŒªèªããããªãããŠããªãªãžãã«ã«è²ãŠäžããŠããããšãããŠé ããã°å¹žãã§ãã
1. æé è¡ç
ã1-1 åã
ã®æ£è
ã®ã±ã¢ãŒååŸã«ãç³é¹žã𿵿°Žã«ããææŽãããã¢ã«ã³ãŒã«è£œå€ã«ããæŠåŒæ¶æ¯ãè¡ãã
ã1-2 äœ¿ãæšãŠæè¢ãççšããŠã±ã¢ãŒãããå Žåã®ååŸããç³é¹žã𿵿°Žã«ããææŽãããã¢ã«ã³ãŒã«è£œå€ã«ããæŠåŒæ¶æ¯ãè¡ãã
ã1-3 ç®ã«èŠããæ±ããä»çããŠããå Žåã¯å¿
ãç³é¹žã𿵿°Žã«ããææŽããè¡ãããããã§ãªãå Žåã¯ãæŠåŒæ¶æ¯ã§ãè¯ããããããã¢ã«ã³ãŒã«ã«æµææ§ã®ãã埮çç©ã«èæ
®ããŠãé©å®ç³é¹žã𿵿°Žãããã¯æèç³é¹žã𿵿°Žã«ããææŽãã远å ããã
ãæ³šïŒææã¿ãªã«ã¯ãã£ã¹ããŒã¶ãã«ã®ããŒããŒã¿ãªã«ã䜿çšããããã«ããããã®ããšã«ãããææŽãéµå®çãåäžãã蚺çæã®è³ªãè©äŸ¡ããããçµæžçè² æ
ã¯ããã«ååå€ãããšèãã
ãæ³šïŒæŽé¢åšã䜿çšããæææ¶æ¯(ãã€ã¹ã³æ³)ã¯ãäžç¢ºå®ãªæ¶æ¯æ³ã§ã§ãããæå¹ã«æ¶æ¯ã§ããªãããè¡ããªã
2. æè¢
ã2-1 è¡æ¶²/äœæ¶²ã«ã¯ãçŽæ¥è§Šããªãããã«äœæ¥ããããšãååã§ãããè¡æ¶²/äœæ¶²ã«è§Šããå¯èœæ§ã®é«ãäœæ¥ãè¡ããšãã¯ãäœ¿ãæšãŠæè¢ãççšããã
ã2-2 æè¢ãççšããå®å¿æãããæ±æããæè¢ã§ãããããã¢ãããªã©ã«è§Šããªãããæ³šæããã ããã
2-3 ãã£ã¹ããŒã¶ãã«æè¢ã¯å䜿çšãããæ£è
(åŠçœ®)ããšã®äº€æãååã§ããããããåŸãç¹°ãè¿ã䜿çšããå Žåã«ã¯ããã®ã€ã©ã¢ã«ã³ãŒã«æž
æãå¿
èŠã§ããã
3. å人çé²è·çšå ·(personal protective equipments PPE)
ã3-1 æ£è
ãšæ¿åãªæ¥è§Šãããå Žåãè¡æ¶²/äœæ¶²ãé£ã³æ£ãå¯èœæ§ãããå Žåã¯ãPPE(ã¬ãŠã³ããŸãã¯ãšããã³ããŽãŒã°ã«ããã§ãŒã¹ã·ãŒã«ããªã©ã®ç®ã®ä¿è·å
·ãæè¢ããã®ä»ã®é²è·çšå
·)ãççšããã
4. å»çåšå ·ã»åšæ
ã4-1 æ»
èç©ã®ä¿ç®¡ã¯ãæ±æãèµ·ãããªãããæ³šæãããæ±æãèªãããããšãã¯ã廿£ããããã¯ãåæ»
èããã䜿çšã®éãå®å
šä¿åæé(æå¹æé)ãéµå®ããã
ã4-2 æ»
èæžã¿åšå
·ã»åšæã䜿çšããéã¯ãç¡èé(æ»
èãããã¬ãŒãäžãªã©)ã§æ»
èæè¢ççšã®äžã§åãæ±ãã
ã4-3 éç¡èéã§ãéæ»
èç©ãšæ»
èç©ãšãæ··ããŠäœ¿çšããããšã¯æå³ããªãã
5. ãªãã³é¡
ã5-1 å
±çšãããªãã³é¡(ã·ãŒãããããããããªã©)ã¯ç±æ°Žæ¶æ¯ãçµãŠå䜿çšãã
ã5-2 ç±æ°Žæ¶æ¯ãå©çšã§ããªãå Žåã«ã¯ã次äºå¡©çŽ é
žãããªãŠã ãªã©ã§æŽæ¿¯ååŠçãã(250ppm(5%次äºå¡©çŽ é
žãããªãŠã ãªã200ååžé)以äžãïŒïŒâãïŒå以äž)ã
ãæ³šïŒè¡æ¶²ã®ä»çãããªãã³ã¯ãè¡æ¶²ãæŽãèœãšããŠããæ¬¡äºå¡©çŽ é
žãããªãŠã æ¶æ¯ãã¹ãã§ããããæ±æã®æ¡æ£ã«ååæ³šæããããã®æå³ã«ãããŠããããšãå°åã§ãããå»çæœèšçšç±æ°ŽæŽæ¿¯æ©ãå°å
¥ãã¹ãã§ãã
6. æ¶å管ææç察ç
ã6-1 ç³äŸ¿ïŒçµå£ã®çµè·¯ã鮿ãã芳ç¹ãããææŽããæææ¶æ¯ãéèŠã§ããã
ã6-2 ç³äŸ¿ãåç©ã§æ±æãããç®æã®æ¶æ¯ãå¿
èŠã§ããã
ã6-3 åºé¢çã«ååããå Žåã¯ãæè¢ããã¹ã¯ãççšããéãããã£ãã·ã¥ã§æãåãããã©ã¹ããã¯ããã¯ã«å¯éãããæ±æç®æã®æ¶æ¯ã¯ã次äºå¡©çŽ é
žãããªãŠã ãçšããå¹³æ»ãªè¡šé¢ã§ããã°ã5%溶液ã®50ååžéæ¶²ããã«ãŒãããçã¯10ååžéæ¶²(5,000ppm)ãçšãã10åéæ¥è§Šãããã衚é¢ãžã®åœ±é¿ã«ã€ããŠã¯ãæ¶æ¯åŸãèšåæ
åœè
ãšçžè«ãããèžæ°ã¯ãªãŒããŒããŸãã¯ãèžæ°ã¢ã€ãã³ã§ç±æ¶æ¯(ïŒïŒïŒâïŒå)ããããšãè¯ãã
ã6-4 æ±æç®æããäžè¬çšæé€æ©(è¶
髿§èœãã£ã«ã¿ãŒã§æ¿Ÿéææ°ããç
颿ž
æçšæé€æ©ä»¥å€ã®ãã®)ã§æž
æããããšã¯ãæ±æã空æ°äžã«é£æ£ãããåå ãšãªãã®ã§ãè¡ããªãã
7. æ£è ã®æè¡çéé¢
ã7-1 ç©ºæ°ææã飿²«ææããææçã§ã¯ãæ£è
ã«ãµãŒãžã«ã«ãã¹ã¯ãççšããŠãããã
ã7-2 ç©ºæ°ææã飿²«ææããææçã§ãéé¢ã®å¿
èŠãããå Žåã«ã¯ãç§»éé¢ä¿è
ãžã®ææé²æ¢(N95埮ç²åçšãã¹ã¯ççšãªã©)ã宿œããŠãé©åãªæœèšã«ç޹ä»ç§»éããã
ã7-3 æ¥è§Šææããææçã§ãå
¥é¢ãå¿
èŠãšããå Žåã¯ãææå±éšãå®å
šãªæ¹æ³ã§è¢«èŠããŠé©åãªæœèšã«ç޹ä»ç§»éããã
8. ææççºçæã®å¯Ÿå¿
ã8-1 åã
ã®ææçäŸã¯ãå°éå»ã«çžè«ãã€ã€æ²»çããã
ã8-2 ææçã®æ²»çã«éããŠã¯ãåšèŸºã®ææã®æ¡å€§ã鲿¢ãã€ã€ãé©åã«å®æœããã
ã8-3 ã¢ãŠããã¬ãŒã¯(éå£çºç)ãããã¯ç°åžžçºçãèãããããšãã¯ãå°åä¿å¥æãšé£çµ¡ãå¯ã«ããŠå¯Ÿå¿ããã
9. æèè¬æäžæã®æ³šæ
ã9-1 察象埮çç©ãšå¯Ÿè±¡èåšã®çµç¹å
æ¿åºŠãèæ
®ãã驿§éã®æäžãè¡ããåé¢åŸ®çç©ã®è¬å€æåæ§æ€æ»çµæã«åºã¥ãæèè¬éžæãè¡ãããšãæãŸããã
ã9-2 现èå¹é€çã®æ€æ»çµæãåŸãåã§ããå¿
èŠãªå Žåã¯ãçµéšçæ²»çempiric therapyãè¡ãããªããã°æããªãã
ã9-3 ç¹å¥ãªäŸãé€ããŠïŒã€ã®æèè¬ãé·æéé£ç¶äœ¿çšããããšã¯å³ã«æ
ãŸãªããã°ãªããªã
ã9-4 ã¡ãã·ãªã³èæ§é»è²ãããŠçè(MRSA)ããã³ã³ãã€ã·ã³èæ§è
žçè(VRE)ãå€å€èæ§ç·è¿è(MDRP)ãªã©ç¹å®ã®å€å€èæ§èãä¿èããŠããããç¡çç¶ã®çäŸã«å¯ŸããŠã¯ãæèè¬ã®æäžã«ããé€èã¯è¡ããªãã
ã9-5 å°åã«ãããè¬å€æåæ§ãµãŒãã€ã©ã³ã¹(å°åæ¯æŽãããã¯ãŒã¯ãååŽçãµãŒãã€ã©ã³ã¹ãå»åž«äŒå ±åãªã©)ã®çµæãåç
§ããã
10. äºé²æ¥çš®
ã10-1 äºé²æ¥çš®ãå¯èœãªæææ§æ£è
ã«å¯ŸããŠã¯ãæ¥çš®çãé«ããããšãæå€§ã®å¶åŸ¡çã§ããã
ã10-2 ã¯ã¯ãã³æ¥çš®ã«ãã£ãŠææãäºé²ã§ããçŸæ£(Båèçã麻ç¹ã颚ç¹ãæ°Žçãæµè¡æ§è³äžè
ºçãã€ã³ãã«ãšã³ã¶ç)ã«ã€ããŠã¯ãé©åã«ã¯ã¯ãã³æ¥çš®ãè¡ãã
ã10-3 æ£è
/å»çåŸäºè
å
±ã«å¿
èŠãªã¯ã¯ãã³ã®æ¥çš®çãé«ãã工倫ãããã
11. å»è¬åã®åŸ®çç©æ±æé²æ¢
ã11-1 è¡æ¶²è£œå€(ãããšãªã¹ãããšãã³ãå«ã)ãèèªä¹³å€(ããããã©ãŒã«ãå«ã)ã®åå²äœ¿çšãè¡ã£ãŠã¯ãªããªãã
ã11-2 æŽçé£å¡©æ¶²ã5%ãããŠç³æ¶²ãªã©ã®æ³šå°å€ã®åå²äœ¿çšã¯ååãšããŠè¡ã£ãŠã¯ãªããªããããåå²äœ¿çšããã®ã§ããã°ãå·æä¿åã§24æéãŸã§ã®äœ¿çšã«ãšã©ããã
ãæ³šïŒççé£å¡©æ°Žãªã©ã®åå²äœ¿çšã¯ãçŽ°èæ±æã®ã¿ãªãããBåèçãCåèçãªã©ã®åå ã«ããªã
ãæ³šïŒå®€æž©ä¿åã矩åä»ããŠããè¬å€ã¯ãªãã誀解ã®ãªããããå·æä¿åäžå¯ã§ããã°ãå¯å·å°ã§äœ¿ããªããªã
12. å»çæœèšã®ç°å¢æŽå
ã12-1 åºãããŒãã«ãªã©ã¯æ±æé€å»ãç®çãšããé€å¡µæž
æãéèŠã§ãããæ¹¿åŒæž
æãè¡ãããŸããæ¥åžžçã«æ¶æ¯è¬ã䜿çšããå¿
èŠã¯ãªã
ã12-2 æãé »ç¹ã«è§Šããéšäœã¯ãïŒæ¥ïŒå以äžã®æ°Žæãæž
æãŸãã¯æ¶æ¯è¬(ç颿޻æ§å€ã第åçŽã¢ã³ã¢ãã¥ãŠã å¡©ãã¢ã«ã³ãŒã«ãªã©)ã«ããæž
ææ¶æ¯ã宿œããã
ãæ³šïŒç°å¢æ¶æ¯ã®ããã®æ¶æ¯è¬ã®åŽé§ãæ£åžãç»èžããã³çŽ«å€ç·ç
§å°ããªãŸã³æ®ºèã¯ãäœæ¥è
ãæ£è
ã«å¯ŸããŠæå®³ã§ãã宿œããªã